Autoantibodies pp 113-131 | Cite as

Measurement of Autoantibodies to Gastric H+,K+-ATPase (ATP4A/B) Using a Luciferase Immunoprecipitation System (LIPS)

  • Edith Lahner
  • Ilaria Marzinotto
  • Cristina Brigatti
  • Howard Davidson
  • Janet Wenzlau
  • Lorenzo Piemonti
  • Bruno Annibale
  • Vito LampasonaEmail author
Part of the Methods in Molecular Biology book series (MIMB, volume 1901)


The Luciferase Immuno Precipitation System (LIPS) enables the detection of specific serum antibodies by immunoprecipitation of recombinant antigens tagged with a luciferase reporter. Here we describe LIPS assays for the quantification of autoantibodies to the H+, K+-ATPase A (ATP4A) and B (ATP4B) subunits, two serological markers of autoimmune atrophic gastritis and pernicious anemia. In particular, we will describe the expression of luciferase-tagged recombinant ATP4A and ATP4B, their immunoprecipitation with test sera, the recovery and washing of immune-complexes with a protein-A coated resin, and the quantification of autoantibodies by addition of a luciferase substrate and the measurement of the light output from captured luciferase-tagged antigens.

Key words

Atrophic gastritis Autoimmune gastritis Autoantibodies ATP4A ATP4B Gastric proton pump H+,K+-ATPase LIPS Luciferase immunoprecipitation system EIA Enzyme immunoassay 



E.L. and B.A. acknowledge support from University Sapienza 2013–2014. H.W.D. and J.M.W. acknowledge support from NIH grant R01 DK052068 (to H.W.D.). I.M., C.B., L.P., and V.L. acknowledge that their work was carried out within the framework of the “Ivascomar project, Cluster Tecnologico Nazionale Scienze della Vita ALISEI, Italian Ministry of Research” and with the support of the Associazione Italiana per la Ricerca sul Cancro (AIRC, bando 5 × 1000 N_12182). The authors wish to thank Carlo Lombardoni for his help in drawing Fig. 1.


  1. 1.
    Chourasia M, Sastry GM, Sastry GN (2005) Proton binding sites and conformational analysis of H+K+-ATPase. Biochem Biophys Res Commun 336:961–966CrossRefGoogle Scholar
  2. 2.
    Shin JM, Munson K, Vagin O et al (2009) The gastric HK-ATPase: structure, function, and inhibition. Pflugers Arch 457:609–622CrossRefGoogle Scholar
  3. 3.
    Neumann WL, Coss E, Rugge M et al (2013) Autoimmune atrophic gastritis—pathogenesis, pathology and management. Nat Rev Gastroenterol Hepatol 10:529–541CrossRefGoogle Scholar
  4. 4.
    Rusak E, Chobot A, Krzywicka A et al (2016) Anti-parietal cell antibodies–diagnostic significance. Adv Med Sci 61:175–179CrossRefGoogle Scholar
  5. 5.
    Lahner E, Esposito G, Pilozzi E et al (2015) Occurrence of gastric cancer and carcinoids in atrophic gastritis during prospective long-term follow up. Scand J Gastroenterol 50:856–865CrossRefGoogle Scholar
  6. 6.
    Vannella L, Lahner E, Osborn J et al (2013) Systematic review: gastric cancer incidence in pernicious anaemia. Aliment Pharmacol Ther 37:375–382CrossRefGoogle Scholar
  7. 7.
    Lahner E, Norman GL, Severi C et al (2009) Reassessment of intrinsic factor and parietal cell autoantibodies in atrophic gastritis with respect to cobalamin deficiency. Am J Gastroenterol 104:2071–2079CrossRefGoogle Scholar
  8. 8.
    Zhang Y, Weck MN, Schöttker B et al (2013) Gastric parietal cell antibodies, Helicobacter pylori infection, and chronic atrophic gastritis: evidence from a large population-based study in Germany. Cancer Epidemiol Biomark Prev 22:821–826CrossRefGoogle Scholar
  9. 9.
    Bergman MP, Vandenbroucke-Grauls CM, Appelmelk BJ et al (2005) The story so far: Helicobacter pylori and gastric autoimmunity. Int Rev Immunol 24:63–91CrossRefGoogle Scholar
  10. 10.
    Lahner E, Annibale B (2009) Pernicious anemia: new insights from a gastroenterological point of view. World J Gastroenterol 15:5121–5128CrossRefGoogle Scholar
  11. 11.
    Minalyan A, Benhammou JN, Artashesyan A et al (2017) Autoimmune atrophic gastritis: current perspectives. Clin Exp Gastroenterol 10:19–27CrossRefGoogle Scholar
  12. 12.
    Toh BH (2014) Diagnosis and classification of autoimmune gastritis. Autoimmun Rev 13:459–466CrossRefGoogle Scholar
  13. 13.
    Wenzlau JM, Gardner TJ, Frisch LM et al (2011) Development of a novel autoantibody assay for autoimmune gastritis in type 1 diabetic individuals. Diabetes Metab Res Rev 27:887–890CrossRefGoogle Scholar
  14. 14.
    Song YH, Ma JY, Mardh S et al (1994) Localization of a pernicious anemia autoantibody epitope on the alpha-subunit of human H,K-adenosine triphosphatase. Scand J Gastroenterol 29:122–127CrossRefGoogle Scholar
  15. 15.
    Burbelo PD, Lebovitz EE, Bren KE et al (2012) Extrapancreatic autoantibody profiles in type I diabetes. PLoS One 7:e45216. Scholar
  16. 16.
    Toh BH, Kyaw T, Taylor R et al (2012) Parietal cell antibody identified by ELISA is superior to immunofluorescence, rises with age and is associated with intrinsic factor antibody. Autoimmunity 45:527–532CrossRefGoogle Scholar
  17. 17.
    Burbelo PD, Ching KH, Klimavicz CM et al (2009) Antibody profiling by luciferase immunoprecipitation systems (LIPS). J Vis Exp 32:e1549. Scholar
  18. 18.
    Burbelo PD, Hirai H, Leahy H et al (2008) A new luminescence assay for autoantibodies to mammalian cell-prepared insulinoma-associated protein 2. Diabetes Care 31:1824–1826CrossRefGoogle Scholar
  19. 19.
    Chandrangsu M, Burbelo PD, Iadarola MJ et al (2012) Development of microLIPS (luciferase immunoprecipitation systems): a novel microfluidic assay for rapid serum antibody detection. Proceedings of the SPIE:8367; id. 83670C.
  20. 20.
    Burbelo PD, Ching KH, Bren KE et al (2011) Searching for biomarkers: humoral response profiling with luciferase immunoprecipitation systems. Expert Rev Proteomics 8:309–316CrossRefGoogle Scholar
  21. 21.
    Lahner E, Brigatti C, Marzinotto I et al (2017) Luminescent Immunoprecipitation System (LIPS) for detection of autoantibodies against ATP4A and ATP4B subunits of gastric proton pump H+,K+-ATPase in atrophic body gastritis patients. Clin Transl Gastroenterol 19(8):e215. Scholar
  22. 22.
    Williams AJK, Norcross AJ, Chandler KA et al (2006) Non-specific binding to protein A Sepharose and protein G Sepharose in insulin autoantibody assays may be reduced by pre-treatment with glycine or ethanolamine. J Immunol Methods 314:170–173. Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Edith Lahner
    • 1
  • Ilaria Marzinotto
    • 2
  • Cristina Brigatti
    • 3
  • Howard Davidson
    • 4
  • Janet Wenzlau
    • 4
  • Lorenzo Piemonti
    • 3
  • Bruno Annibale
    • 1
  • Vito Lampasona
    • 2
    Email author
  1. 1.Medical-Surgical Department of Clinical Sciences and Translational Medicine, Sant’Andrea HospitalSapienza University of RomeRomeItaly
  2. 2.Division of Genetics and Cell BiologyIRCCS San Raffaele Scientific InstituteMilanItaly
  3. 3.Beta Cell Biology Unit, Diabetes Research InstituteIRCCS San Raffaele Scientific InstituteMilanItaly
  4. 4.Barbara Davis Center for DiabetesUniversity of Colorado Anschutz Medical CampusAuroraUSA

Personalised recommendations